Chile vs Equatorial Guinea: Tuberculosis treatment success rate by type
Chile
69
in 2023
Equatorial Guinea
68
in 2023
Chile rank
155th
Equatorial Guinea rank
157th
Tuberculosis treatment success rate by type over time
- Chile
- Equatorial Guinea
How they compare
Chile currently reports 69 against 68 in Equatorial Guinea, a difference of 1.
The two have swapped places 11 times across 19 shared years of data; in 1995 it was Equatorial Guinea ahead.
Chile ranks 155th and Equatorial Guinea ranks 157th of 194 countries.
Across the 4 decades both report, Chile averaged higher in 3 and Equatorial Guinea in 1.
Head to head by decade
| Decade | Chile | Equatorial Guinea | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 78.67 | 82.67 | 4 | Equatorial Guinea |
| 2000s | 78.5 | 57 | 21.5 | Chile |
| 2010s | 67.75 | 67 | 0.75 | Chile |
| 2020s | 72.75 | 70.75 | 2 | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Chile or Equatorial Guinea?
- Chile, at 69 against 68 in Equatorial Guinea as of 2023.
- What is the difference in tuberculosis treatment success rate by type between Chile and Equatorial Guinea?
- 1, with Chile ahead.
- How many years of comparable data are there for Chile and Equatorial Guinea?
- 19 years are reported by both, from 1995 to 2023.
- How do Chile and Equatorial Guinea rank globally for tuberculosis treatment success rate by type?
- Chile ranks 155th and Equatorial Guinea ranks 157th of 194 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.